Showing results (2221-2230 of 2,272) with videos related to

Sort By:
Pageof 228
Cancer Research|February 19, 2025
Targeting PRC2 Enhances the Cytotoxic Capacity of Anti-CD19 CAR-T Cells Against Hematological MalignanciesMaria Leticia R Carvalho, Clara O Andrade, Mariela P Cabral-Piccin, et al.
Neuroscience and Biobehavioral Reviews|March 31, 2023
The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indicationsSamuele Cortese, Katherine McGinn, Mikkel Højlund, et al.
Updates in Surgery|January 3, 2021
Complications and mortality in a cohort of patients undergoing emergency and elective surgery with perioperative SARS-CoV-2 infection: an Italian multicenter study. Teachings of Phase 1 to be brought in Phase 2 pandemicMaurizio De Luca, Alberto Sartori, Antonio Vitiello, et al.
Vaccine|July 2, 2022
Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in BrazilPatricia Mouta Nunes de Oliveira, Daniela P Mendes-de-Almeida, Victor Bertollo Gomes Porto, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 2025
Predictive role of functional respiratory tests in LUng toxicity in stage III NSCLC treated with chemo-, raDIO- and immuno-therapy: PRELUDIO TRIALP M Medusa, N Carro, F Morgillo, et al.
Molecular Psychiatry|June 6, 2022
A systematic review and meta-analysis on prevalence of and risk factors associated with depression, anxiety and insomnia in infectious diseases, including COVID-19: a call to actionKai Yuan, Yong-Bo Zheng, Yi-Jie Wang, et al.
American Journal of Medical Genetics. Part A|February 8, 2020
De novo heterozygous missense and loss-of-function variants in CDC42BPB are associated with a neurodevelopmental phenotypeIlana Chilton, Volkan Okur, Giuseppina Vitiello, et al.
Scientific Reports|August 30, 2024
Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus BevacizumabMargherita Rimini, Margarida Montes, Elisabeth Amadeo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 9, 2013
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the futureYonas E Geda, Lon S Schneider, Laura N Gitlin, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|March 16, 2017
Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppressionJames M Swanson, L Eugene Arnold, Brooke S G Molina, et al.
Pageof 228